Literature DB >> 28939339

Design, virtual screening, molecular docking and molecular dynamics studies of novel urushiol derivatives as potential HDAC2 selective inhibitors.

Hao Zhou1, Chengzhang Wang2, Jianzhong Ye3, Hongxia Chen3, Ran Tao3.   

Abstract

Three series of novel urushiol derivatives were designed by introducing a hydroxamic acid moiety into the tail of an alkyl side chain and substituents with differing electronic properties or steric bulk onto the benzene ring and alkyl side chain. The binding affinity toward HDAC2 of the compounds was screened by Glide docking. The best scoring compounds were processed further with molecular docking, MD simulations and binding free energy studies to analyze the binding modes and mechanisms. Six compounds, 21, 23, 10, 19, 9 and 30, gave Glide scores of -7.9 to -8.5, which revealed that introducing F, Cl, triazole, benzamido, formamido, hydroxyl or nitro substituents onto the benzene ring could increase binding affinity significantly. Molecular docking studies revealed that zinc ion coordination, hydrogen bonding and hydrophobic interactions contributed to the high calculated binding affinities of these compounds toward HDAC2 and that His145, His146, Gly154, Glu103, His183, Asp104, Tyr308 and Phe155 contributed favorably to the binding. MD simulations and binding free energy studies showed that all complexes possessed good stability as characterized by low RMSDs; low RMSFs of residues, moderate hydrogen bonding and zinc ion coordination; and low values of binding free energies. van der Waals and electrostatic interactions provided major contributions to the stability of these complexes. These results show the promising potential of urushiol derivatives as potent HDAC2 binding lead compounds.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  HDAC2 selective inhibitor; Molecular docking; Molecular dynamics; Urushiol derivatives

Mesh:

Substances:

Year:  2017        PMID: 28939339     DOI: 10.1016/j.gene.2017.09.034

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

Review 1.  Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review).

Authors:  Ya-Ru Liu; Jie-Quan Wang; Zhao-Gang Huang; Ruo-Nan Chen; Xi Cao; Dong-Chun Zhu; Hai-Xia Yu; Xiu-Rong Wang; Hai-Yun Zhou; Quan Xia; Jun Li
Journal:  Int J Mol Med       Date:  2021-05-20       Impact factor: 4.101

2.  Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo.

Authors:  Benyu Nan; Zirui Zhao; Kanglun Jiang; Xi Gu; Huawei Li; Xinsheng Huang
Journal:  Acta Pharm Sin B       Date:  2021-07-10       Impact factor: 11.413

3.  Decoding molecular recognition of inhibitors targeting HDAC2 via molecular dynamics simulations and configurational entropy estimation.

Authors:  Suriya Tateing; Nuttee Suree
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

4.  Synthesis and Evaluation of C15 Triene Urushiol Derivatives as Potential Anticancer Agents and HDAC2 Inhibitor.

Authors:  Zhiwen Qi; Chengzhang Wang; Jianxin Jiang
Journal:  Molecules       Date:  2018-05-03       Impact factor: 4.411

5.  Novel C15 Triene Triazole, D-A Derivatives Anti-HepG2, and as HDAC2 Inhibitors: A Synergy Study.

Authors:  Zhiwen Qi; Chengzhang Wang; Jianxin Jiang; Caie Wu
Journal:  Int J Mol Sci       Date:  2018-10-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.